Hwaseong-si
South Korea
17
2025-04-10
The entities that hold a legal rights for patent applications filed by inventor OH Euh Lim:
Euh Lim OH from Hwaseong-si, KR has applied for patents for these inventions. The list has both pending applications and granted patents:
LIVER-TARGETED DRUG AND USE THEREOF
#2 | 2024-01-25HYPOTENSIVE PHARMACEUTICAL COMPOSITION COMPRISING TRIPLE ACTIVATOR HAVING ACTIVITY FOR ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS
#3 | 2024-01-11NOVEL CONJUGATE OF IMMUNE-STIMULATING IL-2 ANALOG AND PREPARATION METHOD THEREOF
#4 | 2023-12-07USE OF TRIGONAL AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS IN TREATMENT OF SEQUELAE FOLLOWING RESPIRATORY INFECTIOUS DISEASES
#5 | 2023-11-02IMMUNOSTIMULATING IL-2 ANALOGS
#6 | 2023-10-05THERAPEUTIC USE OF COMBINATION COMPRISING TRIPLE AGONISTIC LONG-ACTING CONJUGATE OR TRIPLE AGONIST
#7 | 2023-04-20THERAPEUTIC USE OF LONG-ACTING CONJUGATE OF TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON/GLP-1/GIP RECEPTORS FOR LUNG DISEASE
#8 | 2022-07-07TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST
#9 | 2022-01-27NOVEL IMMUNOSUPPRESSIVE INTERLEUKIN 2
#10 | 2021-06-24LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST
#11 | 2020-08-13LONG-ACTING SINGLE-CHAIN INSULIN ANALOG AND CONJUGATE THEREOF
#12 | 2019-07-18Triple glucagon/GLP-1/GIP receptor agonist
#13 | 2019-05-23Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
#14 | 2019-01-03Triple glucagon/GLP-1/GIP receptor agonist
#15 | 2018-11-01Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
#16 | 2018-10-04Insulin analogs and use thereof
#17 | 2017-03-09Insulin analogs and use thereof
1817620 ⎘